The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery
Open accessAbstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTAldehyde Oxidase: An Enzyme of Emerging Importance in Drug DiscoveryDavid C. Pryde*†, Deepak Dalvie‡, Qiyue Hu§, Peter Jones†, R. Scott Obach∥, and Thien-Duc Tran†View Author Information† WorldWide Medicinal Chemistry, Pfizer Global Research and Development, Sandwich, Kent, CT13 9NJ, England‡ Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, 10628 Science Center Drive, La Jolla, California 92121§ WorldWide Medicinal Chemistry, Pfizer Global Research and Development, 10628 Science Center Drive, La Jolla, California 92121∥ Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Eastern Point Road, Groton, Connecticut 06340*To whom correspondence should be addressed. Phone: +44 (1304) 643687. Fax: +44 (0) 1304 651987. E-mail: [email protected]Cite this: J. Med. Chem. 2010, 53, 24, 8441–8460Publication Date (Web):September 20, 2010Publication History Received15 July 2010Published online20 September 2010Published inissue 23 December 2010https://pubs.acs.org/doi/10.1021/jm100888dhttps://doi.org/10.1021/jm100888dreview-articleACS PublicationsCopyright © 2010 American Chemical SocietyRequest reuse permissionsArticle Views12272Altmetric-Citations286LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Anatomy,Metabolism,Oxidation,Peptides and proteins,Rodent models Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Rational design of inhibitors that bind to inactive kinase conformations
Liu, Y., & Gray, N. S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio799 · Cited by 1,094
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Features of Selective Kinase Inhibitors
Knight, Z. A., & Shokat, K. M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.011 · Cited by 657
An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons
Brandon, E. F. A., Raap, C. D., Meijerman, I., Beijnen, J. H., & Schellens, J. H. M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00128-5 · Cited by 567
Chemical mechanisms of catalysis by cytochromes P-450: a unified view
Guengerich, F. P., & Macdonald, T. L. (1984) · Accounts of Chemical Research · doi:10.1021/ar00097a002 · Cited by 484
The pterin molybdenum cofactors.
Rajagopalan, K. V., & Johnson, J. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50001-1 · Cited by 454
Molybdenum and tungsten in biology
Hille, R. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02107-2 · Cited by 429
A comparison of the specificities of xanthine oxidase and aldehyde oxidase
Krenitsky, T. A., Neil, S. M., Elion, G. B., & Hitchings, G. H. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90078-1 · Cited by 341
Molybdenum-containing hydroxylases
Hille, R. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.08.012 · Cited by 320
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activities
Relling, M. V., Lin, J.-S., Ayers, G. D., & Evans, W. E. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.203 · Cited by 314
Okamoto, K., Matsumoto, K., Hille, R., Eger, B. T., Pai, E. F., & Nishino, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400973101 · Cited by 286
GARATTINI, E., MENDEL, R., ROMÃO, M. J., WRIGHT, R., & TERAO, M. (2003) · Biochemical Journal · doi:10.1042/bj20030121 · Cited by 242
Human Liver Aldehyde Oxidase: Inhibition by 239 Drugs
Obach, R. S., Huynh, P., Allen, M. C., & Beedham, C. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003260336 · Cited by 224
Self-citationDrug-Metabolizing Ability of Molybdenum Hydroxylases
Kitamura, S., Sugihara, K., & Ohta, S. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.83 · Cited by 216
Moriwaki, Y., Yamamoto, T., & Higashino, K. (1999) · PubMed · doi:10.14670/hh-14.1321 · Cited by 186
Mammalian aldehyde oxidases: genetics, evolution and biochemistry
Garattini, E., Fratelli, M., & Terao, M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7398-y · Cited by 186
Zimm, S., Collins, J. M., O'Neill, D., Chabner, B. A., & Poplack, D. G. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.254 · Cited by 173
POTENT INHIBITION OF HUMAN LIVER ALDEHYDE OXIDASE BY RALOXIFENE
Obach, R. S. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.1.89 · Cited by 168
Self-citation6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.
Krenitsky, T. A., Hall, W. W., de Miranda, P., Beauchamp, L. M., Schaeffer, H. J., & Whiteman, P. D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.10.3209 · Cited by 161
Rashidi, M., Smith, J. A., Clarke, S. E., & Beedham, C. (1997) · PubMed · Cited by 157
Molybdenum Hydroxylases as Drug-Metabolizing Enzymes
Beedham, C. (1985) · Drug Metabolism Reviews · doi:10.3109/03602538508991432 · Cited by 142
Ziprasidone Metabolism, Aldehyde Oxidase, and Clinical Implications
Beedham, C., Miceli, J. J., & Obach, R. S. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084028.22282.f2 · Cited by 140
Self-citationSpecies-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological Implications
Diamond, S., Boer, J., Maduskuie, T. P., Falahatpisheh, N., Li, Y., & Yeleswaram, S. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032375 · Cited by 138
Johns, D. G. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105641 · Cited by 136
3 Molybdenum Hydroxylases: Biological Distribution and Substrate-Inhibitor Specificity
Beedham, C. (1987) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70420-x · Cited by 129
In Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase
Zientek, M. A., Jiang, Y., Youdim, K. A., & Obach, R. S. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033555 · Cited by 127
Self-citationMuller, A. J., Malachowski, W. P., & Prendergast, G. C. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.831 · Cited by 115
The enzyme “aldehyde oxidase” is an iminium oxidase. Reaction with nicotine Δ1′(5′) iminium ion
Brandänge, S., & Lindblom, L. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91977-6 · Cited by 107
Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver.
Clarke, S. E., Harrell, A. W., & Chenery, R. J. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06527-4 · Cited by 106
Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics
Benedetti, M. S., Whomsley, R., & Baltes, E. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.895 · Cited by 98
Species variation in hepatic aldehyde oxidase activity
Beedham, C., Bruce, S. E., Critchley, D. J. P., Al-Tayib, Y., & Rance, D. J. (1987) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189919 · Cited by 96
Rochat, B., Kosel, M., Boss, G., Testa, B., Gillet, M., & Baumann, P. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00008-2 · Cited by 93
Variation of Hepatic Methotrexate 7-Hydroxylase Activity in Animals and Humans
Kitamura, S., Sugihara, K., Nakatani, K., Ohta, S., Oh-hara, T., Ninomiya, S.-I., Green, C. E., & Tyson, C. A. (1999) · IUBMB Life · doi:10.1080/713803569 · Cited by 93
Mendel, R. R. (2009) · BioFactors · doi:10.1002/biof.55 · Cited by 90
Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase
Lake, B. G., Ball, S. E., Kao, J., Renwick, A. B., Price, R. J., & Scatina, J. (2002) · Xenobiotica · doi:10.1080/00498250210158915 · Cited by 88
Identification of Aldehyde Oxidase as the Neonicotinoid Nitroreductase
Dick, R. A., Kanne, D. B., & Casida, J. E. (2005) · Chemical Research in Toxicology · doi:10.1021/tx049737i · Cited by 87
In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor
Zhang, X., Liu, H.-H., Weller, P. E., Zheng, M., Tao, W., Wang, J., Liao, G., Monshouwer, M., & Peltz, G. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.8 · Cited by 84
Kawashima, K., Hosoi, K., Naruke, T., Shiba, T., Kitamura, M., & Watabe, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14921-5 · Cited by 79
Aldehyde oxidase: Catalysis of the oxidation of N1-methylnicotinamide and pyridoxal
Stanulović, M., & Chaykin, S. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(71)90005-1 · Cited by 78
Moriwaki, Y., Yamamoto, T., Takahashi, S., Tsutsumi, Z., & Hada, T. (2001) · PubMed · doi:10.14670/hh-16.745 · Cited by 76
Hydralazine: A potent inhibitor of aldehyde oxidase activity in vitro and in vivo
Johnson, C., Beedham, C., Godfrey, J., & Stell, P. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90280-1 · Cited by 75
Torres, R. A., Korzekwa, K. R., McMasters, D. R., Fandozzi, C. M., & Jones, J. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0703690 · Cited by 72
Sahi, J., Khan, K. K., & Black, C. (2008) · Drug Metabolism Letters · doi:10.2174/187231208785425818 · Cited by 72
Panoutsopoulos, G. I., Kouretas, D., & Beedham, C. (2004) · Chemical Research in Toxicology · doi:10.1021/tx030059u · Cited by 68
Klecker, R. W., Cysyk, R. L., & Collins, J. M. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.07.053 · Cited by 67
N1-Methylnicotinamide Oxidation in a Number of Mammals
Felsted, R. L., & Chaykin, S. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96175-2 · Cited by 65
Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
Sugihara, K., Kitamura, S., & Tatsumi, K. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07297-6 · Cited by 65
Kitamura, S., & Tatsumi, K. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90742-3 · Cited by 64
Distribution and pathophysiologic role of molybdenum-containing enzymes.
Moriwaki, Y., Yamamoto, T., & Higashino, K. (1997) · PubMed · Cited by 63
Renwick, A. B., Ball, S. E., Tredger, J. M., Price, R. J., Walters, D. G., Kao, J., Scatina, J., & Lake, B. G. (2002) · Xenobiotica · doi:10.1080/00498250210158221 · Cited by 63
Individual Variation in Hepatic Aldehyde Oxidase Activity
Al-Salmy, H. S. (2001) · IUBMB Life · doi:10.1080/152165401753311799 · Cited by 62
Austin, N. E., Baldwin, S. J., Cutler, L., Deeks, N. J., Kelly, P. J., Nash, M., Shardlow, C. E., Stemp, G., Thewlis, K. M., Ayrton, A. D., et al. (2001) · Xenobiotica · doi:10.1080/00498250110056531 · Cited by 62
Nakasa, H., Komiya, M., Ohmori, S., Rikihisa, T., Kiuchi, M., & Kitada, M. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13151-9 · Cited by 62
Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide
Kitamura, S., & Tatsumi, K. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91297-x · Cited by 61
Berger, R., Mezey, É., Clancy, K. P., Harta, G., Wright, R. M., Repine, J. E., Brown, R. H., Brownstein, M., & Patterson, D. (1995) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02255787 · Cited by 60
Second-generation kinase inhibitors
Klebl, B., & Müller, G. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.975 · Cited by 59
Beedham, C. (2001) · Wiley eBooks · doi:10.1002/0470846305.ch5 · Cited by 58
Magee, T. V., Ripp, S. L., Li, B., Buzon, R. A., Chupak, L., Dougherty, T. J., Finegan, S. M., GIRARD, D., Hagen, A. E., Falcone, M. J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900729s · Cited by 54
Self-citationThe identity of rabbit-liver methotrexate oxidase
Johns, D. G., Iannotti, A. T., Sartorelli, A. C., et al. (1965) · Biochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation · doi:10.1016/s0926-6593(65)80164-3 · Cited by 53
In Vitro Study of 6-mercaptopurine Oxidation Catalysed by Aldehyde Oxidase and Xanthine Oxidase
Rashidi, M., Beedham, C., Smith, J. S., & Davaran, S. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.299 · Cited by 52
Metabolism of Retinaldehyde and Other Aldehydes in Soluble Extracts of Human Liver and Kidney
Ambroziak, W., Izaguirre, G., & Pietruszko, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33366 · Cited by 46
Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro
Rodrigues, A. D. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90240-2 · Cited by 46
Dick, R. A., Kanne, D. B., & Casida, J. E. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050230x · Cited by 45
THE METABOLISM OF TOLBUTAMIDE IN RAT LIVER
McDaniel, H. G., Podgainy, H., & BRESSLER, R. C. (1969) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28256-8 · Cited by 45
Acheampong, A., Chien, D. S., Lam, S., Vekich, S., Breau, A., Usansky, J., Harcourt, D. M., MUNK, S. A., Nguyen, H. Q., Garst, M., et al. (1996) · Xenobiotica · doi:10.3109/00498259609167421 · Cited by 45
Panoutsopoulos, G. I., & Beedham, C. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3550 · Cited by 44
Inhibitory effects of flavonoids on aldehyde oxidase activity
Pirouzpanah, S., Hanaee, J., Razavieh, S. V., & Rashidi, M. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701841301 · Cited by 43
Schofield, P. C., Robertson, I. G. C., & Paxton, J. W. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00323-8 · Cited by 41
Miao, Z., Kamel, A. M., & Prakash, C. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004036 · Cited by 41
Inhibitory effects of flavonoids on molybdenum hydroxylases activity
Rashidi, M., & Nazemiyeh, H. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903426164 · Cited by 37
Rodrigues, A. D., Ferrero, J. L., Amann, M. T., Rotert, G. A., Cepa, S. P., Surber, B. W., Machinist, J. M., Tich, N., Sullivan, J. P., & Garvey, D. S. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07569-5 · Cited by 37
In vitro oxidation of pyrazinamide and allopurinol by rat liver aldehyde oxidase
Moriwaki, Y., Yamamoto, T., Nasako, Y., Takahashi, S., Suda, M., Hiroishi, K., Hada, T., & Higashino, K. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90661-f · Cited by 36
5-fluoro-2-pyrimidinone, a liver aldehyde oxidase-activated prodrug of 5-fluorouracil
Guo, X., Lerner-Tung, M. B., Hong-xing, C., Chang, C.-N., Zhu, J., Chang, C.-P., Pizzorno, G., Lin, T., & Cheng, Y. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)98508-7 · Cited by 36
Extremely High Drug-Reductase Activity Based on Aldehyde Oxidase in Monkey Liver.
Kitamura, S., NAKATANI, K., Ohashi, K., et al. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.856 · Cited by 34
Targeting the unactivated conformations of protein kinases for small molecule drug discovery
Alton, G., & Lunney, E. A. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.6.595 · Cited by 33
Strain differences of liver aldehyde oxidase activity in rats.
Sugihara, K., Kitamura, S., & Tatsumi, K. (1995) · PubMed · Cited by 31
Ghafourian, T., & Rashidi, M. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.1066 · Cited by 30
Kitamura, S., Suzuki, T., Kadota, T., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.2.179 · Cited by 29
Species Differences in Oral Bioavailability of Methotrexate between Rats and Monkeys.
Kuroda, T., NAMBA, K., TORIMARU, T., Kawashima, K., & Hayashi, M. (2000) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.23.334 · Cited by 28
Moriyasu, A., Sugihara, K., Nakatani, K., Ohta, S., & Kitamura, S. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.485 · Cited by 28
Biotransformation of carbazeran in guinea pig: Effect of hydralazine pretreatment
Critchley, D. J. P., Rance, D. J., & Beedham, C. (1994) · Xenobiotica · doi:10.3109/00498259409043219 · Cited by 26
Robertson, I. G. C., Palmer, B. D., Officer, M., Siegers, D. J., Paxton, J. W., & Shaw, G. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90585-s · Cited by 26
Panoutsopoulos, G. I., & Beedham, C. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3527 · Cited by 26
Acidic metabolites of tamoxifen. Aspects of formation and fate in the female rat.
Ruenitz, P. C., & Bai, X. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06739-x · Cited by 26
Oxidation of Selected Pteridine Derivatives by Mammalian Liver Xanthine Oxidase and Aldehyde Oxidase
Hodnett, C. N., McCormack, J. J., & Sabean, J. A. (1976) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600650806 · Cited by 25
Johns, D. G., Spector, T., & ROBINS, R. K. (1969) · Biochemical Pharmacology · doi:10.1016/0006-2952(69)90352-9 · Cited by 25
Itoh, K., Yamamura, M., Muramatsu, S., et al. (2005) · Xenobiotica · doi:10.1080/00498250500202106 · Cited by 24
An extremely potent anilinoacridine inhibitor of aldehyde oxidase
Gormley, P. E., Rossitch, E., D'Anna, M. E., & Cysyk, R. L. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90589-2 · Cited by 24
JONES, P. G., Atack, J. R., Braun, M. P., Cato, B. P., Chambers, M. S., O'Connor, D. V., Cook, S. M., Hobbs, S. C., Maxey, R., Szekeres, H. J., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.11.012 · Cited by 23
Self-citationAnderson, L. W., Collins, J. M., Klecker, R. W., et al. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0962-3 · Cited by 23
Panoutsopoulos, G. I., Kouretas, D., Gounaris, E. G., & Beedham, C. (2004) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190585 · Cited by 21
Porter, D. J. T., Harrington, J. A., Almond, M. R., Lowen, G. T., Zimmerman, T. P., & Spector, T. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90388-3 · Cited by 21
Methadone: a potent inhibitor of rat liver aldehyde oxidase
Robertson, I. G. C., & Gamage, R. S. K. A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90192-9 · Cited by 20
The fate of dibenz[b,f]-1,4-oxazepine (CR) in the rat. Part II. Metabolism in vitro
Furnival, B., Harrison, J. M., Newman, J., et al. (1983) · Xenobiotica · doi:10.3109/00498258309052274 · Cited by 19
Inter-strain variability in aldehyde oxidase activity in the mouse
Al-Salmy, H. S. (2002) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/s1532-0456(02)00057-1 · Cited by 16
O'Connor, D. V., JONES, P. G., Chambers, M. S., Maxey, R., Szekeres, H. J., Szeto, N., Scott‐Stevens, P., MacLeod, A. M., Braun, M. P., & Cato, B. P. (2006) · Xenobiotica · doi:10.1080/00498250600567903 · Cited by 14
Self-citationDesign and optimisation of potent gp120-CD4 inhibitors
Tran, T.-D., Adam, F. M., Calo, F., Fenwick, D. R., Fok‐Seang, J., Gardner, I. B., Hay, D. A., Perros, M., Rawal, J. K., Middleton, D. S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.102 · Cited by 11
Self-citationPurification of aldehyde oxidase from bovine ciliary body
Shimada, S., Mishima, H. K., Nikaido, H., et al. (1989) · Current Eye Research · doi:10.3109/02713688909025807 · Cited by 10
The enzymology of the in–vitro oxidation of prolintane to oxoprolintane
Whittlesea, M. C., & Gorrod, J. W. (1993) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1993.tb00603.x · Cited by 8
Cited by
Modern advances in heterocyclic chemistry in drug discovery
Taylor, A. P., Robinson, R. P., Fobian, Y. M., Blakemore, D. C., Jones, L. H., & Fadeyi, O. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00936k · Cited by 887
An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles
Baumann, M., & Baxendale, I. R. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.265 · Cited by 841
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Maia, L. B., & Moura, J. J. G. (2014) · Chemical Reviews · doi:10.1021/cr400518y · Cited by 401
The role of aldehyde oxidase in drug metabolism
Garattini, E., & Terao, M. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.663352 · Cited by 174
Metadata
- Authors
- Pryde, D. C., Dalvie, D., Hu, Q., Jones, P., Obach, R. S., & Tran, T.-D.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-09-20
- Volume
- 53
- Issue
- 24
- Pages
- 8441-8460
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2315921289
- Cited by
- 345
- References
- 101
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.